TMPRSS2 and COVID-19: The potential protective effects of estrogen in lung and cardiovascular pathologies associated with COVID-19 are not limited to ACE2-R expression and may also involve transmembrane protease/serine protease 2 [TMPRSS2], ADAM metallopeptidase domain ADAM-17 and ACE2 expression [91].